New ADC Results Mixed in Metastatic Breast Cancer

Source link :

CHICAGO — The landscape of antibody-drug conjugates, or ADCs, continues to grow more crowded in metastatic breast cancer. Indications are expanding, new agents are emerging, combinations with other drug classes are being tested, and many patients with this disease are now receiving more than one ADC. ADCs use antibodies to bind to the surface proteins […]

Author : News Health

Publish date : 2024-07-10 09:28:15

Copyright for syndicated content belongs to the linked Source.